Eurobio Scientific Société anonyme (ENXTPA: ALERS)
Health Care · Biotechnology · FR
€25.20
+0.40% today · -1.8% 1Y
Eurobio Scientific Société anonyme (ENXTPA: ALERS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $284.43M and employs 343 people.
Over the last twelve months the share price has lost 1.8%, trading between 19.20 and 25.55.
Tweenvest scores Eurobio Scientific Société anonyme across four factors: quality 67/100, value 51/100, growth 27/100. Its strongest factor is quality.
ALERS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $284.43M
- Revenue (TTM)
- $196.80M
- P/E
- 35.86
- EPS
- 0.70
- Dividend yield
- —
- Beta (5Y)
- 0.59
- 52-week high
- €25.55
- 52-week low
- €19.20
- Avg volume (3M)
- —
- Shares outstanding
- 10.07M
- Employees
- 343
- Next earnings
- —
About Eurobio Scientific Société anonyme
Eurobio Scientific S.A. specializes in the conceptualization, development, and distribution of sophisticated diagnostic products. Its key therapeutic and research domains include transplantation, infectious illnesses, life sciences, and oncology. The company's portfolio features the Tetanus Quick Stick, an essential emergency diagnostic for rapidly determining a patient's tetanus vaccination status. It also distributes cell culture media, molecular biology reagents, and proprietary antibody solutions. Proprietary developments from Eurobio Scientific encompass the BJI InoPlex, a multiplex serological test for diagnosing prosthetic joint infections, and the EBX-044 PCR test, utilized for identifying SARS-CoV-2 variants. Its licensed offerings include AlloMap, a gene-expression profiling blood test designed for the ongoing surveillance of heart transplant recipients. The firm, initially named Diaxonhit, changed its corporate identity to Eurobio Scientific S.A. in June 2018. Founded in 1997, the company is headquartered in Les Ulis, France.
- ISIN
- FR0013240934
- Founded
- 1997
- Listed since
- Nov 18, 2005
- Exchange
- Euronext Paris
- Currency
- EUR
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Lexeo Therapeutics, Inc.NasdaqGM: LXEO | $289.61M | $3.21 | -9.07% |
| Clinuvel Pharmaceuticals LimitedASX: CUV | $287.82M | AU$8.20 | +0.86% |
| Abeona Therapeutics Inc.NasdaqCM: ABEO | $287.64M | $4.96 | -1.39% |
| CytoDyn Inc.OTCPK: CYDY | $287.21M | $0.20 | -11.89% |
| Rocket Pharmaceuticals, Inc.NasdaqGM: RCKT | $281.02M | $2.63 | +2.73% |
| Perspective Therapeutics, Inc.NYSEAM: CATX | $280.81M | $2.71 | +10.16% |
| X4 Pharmaceuticals, Inc.NasdaqCM: XFOR | $280.59M | $2.79 | -1.41% |
| Vanda Pharmaceuticals Inc.NasdaqGM: VNDA | $279.94M | $4.53 | -2.16% |
Figures last refreshed Oct 4, 2026.